Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers.

Gels are considered to be the most suitable delivery vehicle for iontophoresis, as they can be easily amalgamated with the iontophoretic delivery system and can also match the contours of the skin. Insulin was used as a model peptide for large peptides in the molecular weight range of 3-7 kDa. A gel formulation of insulin was formulated using poloxamer 407 and was evaluated by ex vivo and in vivo skin permeation studies in rat with chemical enhancer and/or iontophoresis. The poloxamer gel was physically and chemically stable during the storage period. In ex vivo studies, both linoleic acid and menthone in combination with iontophoresis showed a synergistic enhancement of insulin permeation. The plasma insulin concentration (PIC) was highest with linoleic acid pre-treatment, in agreement with ex vivo permeation studies, but the reduction in plasma glucose levels (PGL) was comparable to iontophoresis. Menthone pre-treatment resulted in rapid attainment of peak PIC, but the reduction in PGL was less than other treatment groups. There was no direct relation between PIC and PGL and is attributed to the fact that the action of insulin in mediated by a cascade of cellular mechanisms, before a reduction in PGL is observed. However, iontophoresis either alone or in combination with linoleic acid produced a reduction in PGL to the extent of 36-40%. A combination of chemical enhancers and iontophoresis caused greater skin irritation than when either of them was used alone.

[1]  J. Bouwstra,et al.  Modes of action of terpene penetration enhancers in human skin; Differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies , 1996 .

[2]  Russell O. Potts,et al.  Evidence that Oleic Acid Exists in a Separate Phase Within Stratum Corneum Lipids , 1991, Pharmaceutical Research.

[3]  R. Guy,et al.  In vitro and in vivo iontophoresis of a tripeptide across nude rat skin , 1992 .

[4]  Adrian C. Williams,et al.  Terpenes and the Lipid–Protein–Partitioning Theory of Skin Penetration Enhancement , 2004, Pharmaceutical Research.

[5]  B. Testa,et al.  The skin as a drug-metabolizing organ. , 1978, Drug metabolism reviews.

[6]  R. Bronaugh,et al.  Determination of percutaneous absorption by in vitro techniques , 2001, Percutaneous Absorption.

[7]  W. Ritschel,et al.  Percutaneous absorption of rosmarinic acid in the rat. , 1989, Methods and findings in experimental and clinical pharmacology.

[8]  S. C. Miller,et al.  In vitro release of nicotinic acid alkyl esters from poloxamer vehicles , 1990 .

[9]  J. Trimmer,et al.  Transdermal delivery of human insulin to albino rabbits using electrical current. , 1989, The American journal of the medical sciences.

[10]  L. John,et al.  Blood glucose control in diabetic rats by transdermal iontophoretic delivery of insulin , 1988 .

[11]  R Panchagnula,et al.  Transdermal iontophoresis revisited. , 2000, Current opinion in chemical biology.

[12]  J. Hadgraft,et al.  Topical Application of Penetration Enhancers to the Skin of Nude Mice: a Histopathological Study , 1989, The Journal of pharmacy and pharmacology.

[13]  O. Pillai,et al.  Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers. , 2004, International journal of pharmaceutics.

[14]  K. Shung,et al.  Hydrogels with enhanced mass transfer for transdermal drug delivery. , 1996, Journal of pharmaceutical sciences.

[15]  R Panchagnula,et al.  Transdermal iontophoresis. Part II: Peptide and protein delivery. , 1999, Methods and findings in experimental and clinical pharmacology.

[16]  R. Reid Peptide and Protein Drug Analysis , 1999 .

[17]  B. Kári Control of Blood Glucose Levels in Alloxan-diabetic Rabbits by Iontophoresis of Insulin , 1986, Diabetes.

[18]  B. W. Barry Lipid-Protein-Partitioning theory of skin penetration enhancement , 1991 .

[19]  A. Kibbe Handbook of Pharmaceutical Excipients , 2003 .

[20]  B. Magnusson,et al.  Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin releasing hormone in human epidermis , 1997 .

[21]  R Panchagnula,et al.  Transdermal iontophoresis. Part I: Basic principles and considerations. , 1999, Methods and findings in experimental and clinical pharmacology.

[22]  V. Lee,et al.  Trends and Future Perspectives in Peptide and Protein Drug Delivery , 1995 .

[23]  Pharmacokinetic‐pharmacodynamic modelling of human insulin: validity of pharmacological availability as a substitute for extent of bioavailability , 2001, The Journal of pharmacy and pharmacology.

[24]  H. Junginger,et al.  In Vitro Human Skin Barrier Modulation by Fatty Acids: Skin Permeation and Thermal Analysis Studies , 2004, Pharmaceutical Research.

[25]  O. Pillai,et al.  Insulin therapies - past, present and future. , 2001, Drug discovery today.

[26]  M. Singh,et al.  Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. , 2000, Current medicinal chemistry.

[27]  T. Freeman,et al.  Effect of penetration enhancers and iontophoresis on the ultrastructure and cholecystokinin-8 permeability through porcine skin. , 1997, Journal of pharmaceutical sciences.

[28]  S. Mallapragada,et al.  Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Mandip Singh,et al.  Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. , 2002, International journal of pharmaceutics.

[30]  Yie W. Chien,et al.  Hydrogel-Based lontotherapeutic Delivery Devices for Transdermal Delivery of Peptide/Protein Drugs , 1993, Pharmaceutical Research.

[31]  Y. Chien,et al.  Facilitated transdermal transport of insulin. , 1987, Journal of pharmaceutical sciences.

[32]  Howard I. Maibach,et al.  Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methods, Fourth Edition , 2005 .

[33]  J. M. Marchetti,et al.  Influence of lecithin on some physical chemical properties of poloxamer gels: rheological, microscopic and in vitro permeation studies. , 1999, International journal of pharmaceutics.

[34]  B. Aungst Structure/Effect Studies of Fatty Acid Isomers as Skin Penetration Enhancers and Skin Irritants , 1989, Pharmaceutical Research.

[35]  C. Zakzewski,et al.  Transdermal delivery of regular insulin to chronic diabetic rats: effect of skin preparation and electrical enhancement. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[36]  O. Pillai,et al.  Transdermal iontophoresis of insulin. V. Effect of terpenes. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[37]  S. Mallapragada,et al.  Experimental investigation and mathematical modeling of Pluronic F127 gel dissolution: drug release in stirred systems. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Y. Kalia,et al.  Transdermal drug delivery: overcoming the skin's barrier function. , 2000, Pharmaceutical science & technology today.

[39]  T. Johnston,et al.  Sustained-release interleukin-2 following intramuscular injection in rats , 1995 .

[40]  Makoto Haga,et al.  Transdermal iontophoretic delivery of insulin using a photoetched microdevice , 1997 .

[41]  P. Elias,et al.  Structural and functional effects of oleic acid and iontophoresis on hairless mouse stratum corneum. , 2000, The Journal of investigative dermatology.

[42]  S. Bolton,et al.  Effect of chemical enhancers and conducting gels on iontophoretic transdermal delivery of cromolyn sodium , 1994 .

[43]  S. Ramanathan,et al.  The use of chitosan gels as matrices for electrically-modulated drug delivery. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[44]  T. Johnston,et al.  Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat. , 1992, Journal of pharmaceutical sciences.

[45]  P. Ramarao,et al.  Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Adrian C. Williams,et al.  The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs , 1991 .

[47]  J. Hadgraft,et al.  Pharmaceutical skin penetration enhancement , 1993 .

[48]  Seung Hun Lee,et al.  The Pretreatment Effect of Chemical Skin Penetration Enhancers in Transdermal Drug Delivery Using Iontophoresis , 1999, Skin Pharmacology and Physiology.

[49]  Tsutomu Suzuki,et al.  Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon , 1997 .

[50]  W. Shi,et al.  Transdermal Iontophoretic Delivery of Therapeutic Peptides/Proteins I: Insulin , 1987, Annals of the New York Academy of Sciences.

[51]  A. Banga,et al.  Systemic delivery of therapeutic peptides and proteins , 1988 .

[52]  L. Saccá,et al.  Direct assessment of splanchnic uptake and metabolic effects of human and porcine insulin. , 1984, The Journal of clinical endocrinology and metabolism.

[53]  T. Nagai,et al.  Iontophoretic transdermal absorption of insulin and calcitonin in rats with newly-devised switching technique and addition of urea , 1997 .